Contribution of lead to hypertension with renal impairment

Insights

Elevated lead levels, identified by the EDTA lead-mobilization test, were found in men with essential hypertension and reduced kidney function. This suggests lead exposure may contribute to hypertension-related renal disease.

Area of Science:

  • Environmental Health
  • Nephrology
  • Cardiovascular Disease

Background:

  • Essential hypertension, a common condition, has an unknown cause.
  • Lead poisoning is a potential, though often overlooked, cause of hypertension.
  • The EDTA lead-mobilization test effectively measures cumulative lead absorption.

Purpose of the Study:

  • To investigate the association between cumulative lead absorption and essential hypertension.
  • To determine if lead exposure plays a role in hypertension-related renal impairment.

Main Methods:

  • Utilized the EDTA lead-mobilization test to assess lead body stores in 48 men with essential hypertension.
  • Compared lead excretion in hypertensive patients with and without reduced renal function.
  • Included a control group of 22 patients with renal impairment from other causes.

Main Results:

  • Hypertensive patients with reduced renal function (serum creatinine >1.5 mg/dL) showed significantly higher mobilizable lead levels.
  • Lead excretion in hypertensive patients was significantly greater than in control patients with similar renal impairment.
  • These findings were not attributable to renal disease alone.

Conclusions:

  • Cumulative lead absorption may be an etiologic factor in "essential" hypertension, particularly in cases with renal compromise.
  • The EDTA test can identify patients with elevated lead burdens contributing to their hypertension.
  • Re-evaluating the etiology of essential hypertension to include lead exposure is warranted.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...